Ann Dermatol.  2015 Apr;27(2):210-212. 10.5021/ad.2015.27.2.210.

Frequency of Antinuclear Antibody Positivity in Patients with Pattern Hair Loss

• Choi WJ
• Kim JE
• Kang H

• KMID: 2264814
• DOI: http://doi.org/10.5021/ad.2015.27.2.210

Abstract

No abstract available.

MeSH Terms

Antibodies, Antinuclear*
Hair*
Humans
Antibodies, Antinuclear

Figure

• 

  Fig. 1 Antinuclear antibody positivity of patients with pattern hair loss (PHL) according to demographic information.

Reference

1. Solomon DH, Kavanaugh AJ, Schur PH. American College of Rheumatology Ad Hoc Committee on Immunologic Testing Guidelines. Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis Rheum. 2002; 47:434–444.

2. Li QZ, Karp DR, Quan J, Branch VK, Zhou J, Lian Y, et al. Risk factors for ANA positivity in healthy persons. Arthritis Res Ther. 2011; 13:R38.

3. Lee WS, Ro BI, Hong SP, Bak H, Sim WY, Kim do W, et al. A new classification of pattern hair loss that is universal for men and women: basic and specific (BASP) classification. J Am Acad Dermatol. 2007; 57:37–46.

4. Nyholt DR, Gillespie NA, Heath AC, Martin NG. Genetic basis of male pattern baldness. J Invest Dermatol. 2003; 121:1561–1564.

5. Cooper GS, Parks CG, Schur PS, Fraser PA. Occupational and environmental associations with antinuclear antibodies in a general population sample. J Toxicol Environ Health A. 2006; 69:2063–2069.

6. Nilsson BO, Skogh T, Ernerudh J, Johansson B, Löfgren S, Wikby A, et al. Antinuclear antibodies in the oldest-old women and men. J Autoimmun. 2006; 27:281–288.

7. Guevara-Gutiérrez E, Yinh-Lao J, García-Gutiérrez P, Tlacuilo-Parra A. Frequency of antinuclear antibodies in mestizo Mexican children with morphea. Clin Rheumatol. 2010; 29:1055–1059.